$150 Million in Emergency FDA Funding Approved; 2009 Process Halted
On June 18, House Democratic and Republican leaders brokered a compromise on the FY 2008 emergency supplemental appropriations bill, one which the White House will reportedly approve today. The emergency funding bill provides an immediate $150 million funding increase for the FDA to bolster the regulatory efforts of the agency and improve US food and drug safety system. While a large portion of these new resources will be allocated to the Center for Food Safety, the Center for Drug Evaluation and Research (CDER) will receive over $28 million, the Center for Biologics Evaluation and Research (CBER) will receive over $12.5 million, and the Center for Devices and Radiological Health (CDRH) will receive over $20 million.
The House Agriculture Subcommittee also recently approved a FY 2009 budget allocation that includes nearly $2.1 billion for the FDA. This allocation is an increase of $282 million over the Administration’s budget proposal, though it is generally in line with a recent Administration budget revision. The House and Senate appropriations committees will resume consideration of FY 2009 appropriations for FDA after Congress returns from the July 4th recess.
ACT-AD is encouraged by recent steps taken by Congress to provide additional support for FDA. The Coalition hopes that the additional funding will help CDER, CBER and CDRH enhance their evaluation of neurological disease treatments, including those for Alzheimer’s disease.